PROGRESS WORTH SHARING
We share news when we have something important to say. These are the milestones, publications, and moments that mark our journey.
Born in October
Meet Petunia, the calf whose MSUD gene therapy study helped lay the scientific groundwork for Plowshare Therapies' gene therapy program.
Plowshare Therapies Raises $6.7 Million to Advance MSUD Gene Therapy
Plowshare Therapies raised $6.7 million to advance its investigational dual-gene therapy for Maple Syrup Urine Disease, through manufacturing, toxicology, and regulatory preparation.
Plowshare Selects OXB as Manufacturing Partner for PLOW-101
The collaboration brings specialized process-development and manufacturing capabilities to Plowshare’s lead gene therapy program for Maple Syrup Urine Disease.
Plowshare Licenses MSUD Gene Therapy from UMass Chan
Plowshare has licensed an investigational gene therapy developed at UMass Chan Medical School to address two genetic forms of Maple Syrup Urine Disease.